Autoimmunity Biologic Solutions Inc.
Biotechnology company · Houston, Texas, United States
Autoimmunity Biologic Solutions Inc. is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2020. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $2.7 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $3.2 million sold in a notice filed in 2026.
Autoimmunity Biologic Solutions at a glance
What does Autoimmunity Biologic Solutions do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $2.7 million in total (2019 to 2022). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $3.2 million sold (2026).
Frequently asked questions about Autoimmunity Biologic Solutions
Where is Autoimmunity Biologic Solutions headquartered?
Autoimmunity Biologic Solutions Inc. is headquartered in Houston, Texas, United States.
What does Autoimmunity Biologic Solutions do?
Autoimmunity Biologic Solutions Inc. is a biotechnology company.
When was Autoimmunity Biologic Solutions founded?
The earliest incorporation on record for Autoimmunity Biologic Solutions Inc. is in 2020, according to public company registers.
Similar companies
- Pulmotect, Inc.Houston, Texas, United States
- Kiromic Biopharma, Inc.Houston, Texas, United States
- March Biosciences, Inc.Houston, Texas, United States
- Fannin Partners, LLCHouston, Texas, United States
- Brevitest Technologies, Inc.Houston, Texas, United States
- Pupil Bio, Inc.Houston, Texas, United States
- Asylia Therapeutics, Inc.Houston, Texas, United States
- Procyrion, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences